Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_24568 | 25 | 0.51 | Mlig455_038127 | Neo: - Age: Down-Up-Down |
CACNA2D2 | Mlig455_038127 {REF} {Length: 4202} {Pfam: von Willebrand factor type A domain [PF13519.8, score=41.5]; von Willebrand factor type A domain [PF00092.30, score=36.2]; von Willebrand factor type A domain [PF13768.8, score=30.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=82.8, Expect=2e-16]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=79.3, Expect=3e-15]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=79.0, Expect=4e-15]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=82.4, Expect=2e-16]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=79.3, Expect=3e-15]} {Celegans: WBGene00007041, tag-180, [Score=62.0, Expect=4e-10]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=430, Expect=2e-140]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.877 | 0.871 | 0.99982 | 1.00000 | |
RegionR2 | 3.089 | 0.871 | 0.85479 | 1.00000 | |
RegionR3 | -2.266 | 0.871 | 0.99969 | 1.00000 | |
RegionR4 | 0.793 | 0.871 | 0.31343 | 0.62904 | |
RegionR5 | -1.542 | 0.871 | 0.93994 | 1.00000 | |
RegionR6 | -2.369 | 0.871 | 0.99960 | 1.00000 | |
RegionR7 | 2.544 | 0.871 | 0.66185 | 1.00000 | |
RegionR8 | -1.125 | 0.871 | 0.99987 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.743 | 0.871 | 0.99978 | 1.00000 | |
RegenerationR2 | -0.372 | 0.871 | 0.96420 | 1.00000 | |
RegenerationR3 | 1.835 | 0.871 | 0.78863 | 0.97853 | |
RegenerationR4 | 0.383 | 0.871 | 0.59644 | 0.91181 | |
RegenerationR5 | -0.906 | 0.871 | 0.33149 | 0.75249 | |
RegenerationR6 | 2.727 | 0.871 | 0.39860 | 0.73635 | |
RegenerationBL | -1.335 | 0.871 | 0.99966 | 1.00000 | |
RegenerationTP | -2.312 | 0.871 | 0.99970 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_24568 | 25 | 0.51 | Mlig455_038127 | Neo: - Age: Down-Up-Down |
CACNA2D2 | 4 | 1.000 | - | 1.000 | 1.000 | 1.000 | - | Mlig455_038127 {REF} {Length: 4202} {Pfam: von Willebrand factor type A domain [PF13519.8, score=41.5]; von Willebrand factor type A domain [PF00092.30, score=36.2]; von Willebrand factor type A domain [PF13768.8, score=30.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=82.8, Expect=2e-16]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=79.3, Expect=3e-15]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=79.0, Expect=4e-15]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=82.4, Expect=2e-16]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=79.3, Expect=3e-15]} {Celegans: WBGene00007041, tag-180, [Score=62.0, Expect=4e-10]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=430, Expect=2e-140]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872} |
2. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 3.608 | 0.878 | - | 1.000 | 0.970 | 0.760 | - | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
3. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
2.894 | 0.953 | - | 0.983 | 0.958 | - | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
4. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
2.88 | 0.930 | - | 0.991 | 0.959 | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
5. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
2.867 | 0.933 | - | 0.977 | 0.957 | - | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
6. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
2.864 | - | - | 0.974 | 0.949 | 0.941 | - | Mlig455_065030 {REF} {Length: 672} | |
7. | MligTC455_25701 | 31 | 0.65 | Mlig455_017477 | Neo: - Age: - |
2.842 | 0.933 | - | 0.956 | 0.953 | - | - | Mlig455_017477 {REF} {Length: 664} {RNA1310_52753} {RNA815_26527} | |
8. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 2.829 | 0.899 | - | 0.994 | 0.936 | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
9. | MligTC455_49304 | 46 | 0.95 | Mlig455_044321 | Neo: - Age: - |
2.823 | 0.897 | - | 0.954 | 0.972 | - | - | Mlig455_044321 {REF} {Length: 701} {RNA1509_20965} {RNA1310_92283} | |
10. | MligTC455_41854 | 80 | 1.67 | Mlig455_034307, Mlig455_067305, Mlig455_067321 | Neo: - Age: - |
2.818 | 0.973 | - | 0.892 | 0.953 | - | - | Mlig455_034307 {REF} {Length: 459} {RNA815_51696.1} Mlig455_067305 {REF} {Length: 466} {RNA815_51696.1} Mlig455_067321 {REF} {Length: 95} {TRANSSPLICED} {NoTransDecoderORF} {RNA815_51696.1} |
|
11. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
2.812 | 0.946 | - | 0.908 | 0.958 | - | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
12. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
2.798 | 0.932 | - | 0.912 | 0.954 | - | - | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
13. | MligTC455_20269 | 75 | 1.57 | Mlig455_032480 | Neo: - Age: - |
CACNG5 | 2.785 | 0.950 | - | 0.911 | 0.924 | - | - | Mlig455_032480 {REF} {Length: 2885} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=68.8]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=50.3]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [RH, Score=105, Expect=7e-25]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [RH, Score=104, Expect=8e-25]} {Dmel: FBgn0064123, stg1, stargazin-like protein, [RH, Score=68.6, Expect=4e-12]} {Smed: dd_Smed_v6_20066_0_1, dd_Smed_v6_20066_0_1, [RH, Score=217, Expect=2e-64]} {RNA1310_28766} {RNA815_15582} |
14. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 2.781 | 0.933 | - | 0.892 | 0.956 | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
15. | MligTC455_42520 | 221 | 4.6 | Mlig455_051277 | Neo: - Age: Down-Up-Up Region-specific R2: 7.331 Region-enriched R2: 7.171/0.00000 Regeneration-downregulated R2: -3.384 Regeneration-depleted R2: -3.384 |
2.772 | 0.932 | - | 0.886 | 0.954 | - | - | Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649} | |
16. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
2.745 | 0.975 | - | 0.805 | 0.965 | - | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
17. | MligTC455_24569 | 17 | 0.35 | Mlig455_039795 | Neo: - Age: - |
CACNA2D2 | 2.743 | - | - | 1.000 | 0.910 | 0.833 | - | Mlig455_039795 {REF} {Length: 4369} {Pfam: VWA N-terminal [PF08399.13, score=79.6]; Cache domain [PF02743.20, score=54.9]; von Willebrand factor type A domain [PF13519.8, score=37.5]; von Willebrand factor type A domain [PF00092.30, score=32.3]; von Willebrand factor type A domain [PF13768.8, score=27.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=182, Expect=5e-46]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=176, Expect=3e-44]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=174, Expect=2e-43]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=182, Expect=3e-46]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=177, Expect=1e-44]; ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=176, Expect=3e-44]} {Dmel: FBgn0028863, CG4587, [Score=149, Expect=5e-36]} {Celegans: WBGene00007041, tag-180, [Score=110, Expect=4e-24]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [RH, Score=1452, Expect=0.0]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872} |
18. | MligTC455_25268 | 55 | 1.15 | Mlig455_000562, Mlig455_030361 | Neo: - Age: - Region-enriched R2: 7.728/0.00671 |
2.742 | - | - | 0.993 | 0.961 | 0.788 | - | Mlig455_000562 {REF} {Length: 844} {Pfam: DNA gyrase inhibitor YacG [PF03884.16, score=19.0]} {RNA1310_51946} {RNA815_48498} Mlig455_030361 {REF} {Length: 1237} {Pfam: DNA gyrase inhibitor YacG [PF03884.16, score=18.5]} {RNA1509_24858} {RNA1310_51946} {RNA815_48498} |
|
19. | MligTC455_24470 | 37 | 0.76 | Mlig455_020119 | Neo: - Age: - |
2.737 | 0.933 | - | 0.847 | 0.957 | - | - | Mlig455_020119 {REF} {Length: 1150} {Pfam: Pancreatic hormone peptide [PF00159.20, score=22.9]} {RNA1310_54016} {RNA815_51613} | |
20. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
2.733 | 0.963 | - | 0.963 | 0.807 | - | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
21. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
2.731 | 0.959 | - | - | 0.952 | 0.820 | - | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
22. | MligTC455_25703 | 225 | 4.7 | Mlig455_017402, Mlig455_030916 | Neo: - Age: - |
2.727 | 0.933 | - | 0.839 | 0.955 | - | - | Mlig455_017402 {REF} {Length: 899} {RNA1310_52753} {RNA815_26527} Mlig455_030916 {REF} {Length: 700} {RNA1310_52753} {RNA815_26527} |
|
23. | MligTC455_36643 | 194 | 4.04 | Mlig455_041343 | Neo: - Age: Up-Down-Up |
2.726 | 0.957 | - | 0.974 | 0.795 | - | - | Mlig455_041343 {REF} {Length: 847} {RNA1509_40031} {RNA1310_41959.1} {RNA815_19701} | |
24. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
2.725 | 0.844 | - | 0.922 | 0.959 | - | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
25. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
2.722 | 0.968 | - | - | 0.904 | 0.850 | - | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
26. | MligTC455_52656 | 121 | 2.51 | Mlig455_062381, Mlig455_062408 | Neo: - Age: Down-Up-Down |
2.721 | 0.957 | - | - | 0.944 | 0.820 | - | Mlig455_062381 {REF} {Length: 2245} {RNA1310_26272} {RNA815_22826} Mlig455_062408 {REF} {Length: 2277} {RNA1310_26272} {RNA815_37592} |
|
27. | MligTC455_26519 | 183 | 3.82 | Mlig455_030983, Mlig455_069440 | Neo: - Age: - |
2.719 | 0.929 | - | 0.833 | 0.957 | - | - | Mlig455_030983 {REF} {Length: 688} {RNA1509_12904} {RNA1310_62229} {RNA815_56172} Mlig455_069440 {REF} {Length: 1096} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=54.9]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
28. | MligTC455_37838 | 40 | 0.83 | Mlig455_012885 | Neo: - Age: Up-Down-Down |
PKDREJ | 2.706 | 0.968 | - | - | 0.945 | 0.793 | - | Mlig455_012885 {REF} {Length: 13341} {Pfam: Polycystin cation channel [PF08016.14, score=221.2]; REJ domain [PF02010.17, score=52.8]; PLAT/LH2 domain [PF01477.25, score=27.5]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=184, Expect=7e-46]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [Score=186, Expect=7e-47]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=178, Expect=3e-44]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=110, Expect=6e-24]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=121, Expect=3e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=260, Expect=1e-69]} {RNA1509_38015} {RNA1310_23208, RNA1509_38015} {RNA1509_38015, RNA815_31966} |
29. | MligTC455_52543 | 184 | 3.83 | Mlig455_034643, Mlig455_062632 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.879/0.00387 |
2.705 | - | - | 0.963 | 0.950 | 0.792 | - | Mlig455_034643 {REF} {Length: 690} {Pfam: Dickkopf N-terminal cysteine-rich region [PF04706.14, score=19.5]} {RNA1310_10592.1} {RNA815_59658} Mlig455_062632 {REF} {Length: 685} {Pfam: Dickkopf N-terminal cysteine-rich region [PF04706.14, score=19.5]} {RNA1310_10592.1} {RNA815_59658} |
|
30. | MligTC455_20122 | 48 | 1 | Mlig455_004561, Mlig455_064755 | Neo: - Age: - |
2.698 | 0.962 | - | 0.779 | 0.957 | - | - | Mlig455_004561 {REF} {Length: 665} {RNA1310_57601} Mlig455_064755 {REF} {Length: 650} {TRANSSPLICED} {RNA1310_57601} |
|
31. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
2.693 | 0.937 | - | 0.804 | 0.952 | - | - | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
32. | MligTC455_46554 | 47 | 0.97 | Mlig455_038253 | Neo: - Age: logFC(26M/2M)=-0.562 |
2.693 | 0.879 | - | 1.000 | - | 0.814 | - | Mlig455_038253 {REF} {Length: 1890} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=60.6]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=94.4, Expect=7e-24]} {RNA1310_40614} {RNA815_32173} | |
33. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
2.688 | 0.772 | - | 0.964 | 0.952 | - | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
34. | MligTC455_49334 | 86 | 1.78 | Mlig455_037751 | Neo: - Age: - |
2.688 | 0.966 | - | - | 0.954 | 0.768 | - | Mlig455_037751 {REF} {Length: 708} {RNA1509_25826} {RNA1310_47741} {RNA815_23874} | |
35. | MligTC455_48604 | 173 | 3.6 | Mlig455_031074 | Neo: - |
2.683 | 0.927 | - | 0.798 | 0.958 | - | - | Mlig455_031074 {REF} {Length: 652} {RNA1310_66509} | |
36. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 2.674 | 0.967 | - | - | 0.896 | 0.811 | - | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
37. | MligTC455_44956 | 144 | 2.99 | Mlig455_061510 | Neo: - Age: - |
2.665 | 0.860 | - | 0.849 | 0.956 | - | - | Mlig455_061510 {REF} {Length: 493} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1} {RNA815_41767} | |
38. | MligTC455_29238 | 48 | 1.01 | Mlig455_063305 | Neo: - Age: - |
2.629 | 0.858 | - | 0.999 | - | 0.772 | - | Mlig455_063305 {REF} {Length: 892} {TRANSSPLICED} {RNA1310_67367} {RNA815_37220} | |
39. | MligTC455_21182 | 238 | 4.96 | Mlig455_000068, Mlig455_063733 | Neo: - Age: Down-Up-Up Region-enriched R4: 5.301/0.04587 |
2.628 | 0.950 | - | 0.884 | 0.794 | - | - | Mlig455_000068 {REF} {Length: 468} {Pfam: Pancreatic hormone peptide [PF00159.20, score=23.7]} {RNA1310_81800.1} {RNA815_55075} Mlig455_063733 {REF} {Length: 531} {Pfam: Pancreatic hormone peptide [PF00159.20, score=20.7]} {RNA1310_81800.1} {RNA815_55075} |
|
40. | MligTC455_33239 | 57 | 1.18 | Mlig455_006962 | Neo: - Age: - |
CACNG5 | 2.619 | 0.970 | - | 0.870 | 0.779 | - | - | Mlig455_006962 {REF} {Length: 1957} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=72.5]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=60.2]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [Score=91.3, Expect=5e-20]; ENSG00000105605, CACNG7, calcium voltage-gated channel auxiliary subunit gamma 7, [Score=89.0, Expect=4e-19]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [Score=90.1, Expect=9e-20]; ENSMUSG00000069806, Cacng7, calcium channel, voltage-dependent, gamma subunit 7, [Score=89.0, Expect=3e-19]; ENSMUSG00000096998, Cacng7, calcium channel, voltage-dependent, gamma subunit 7, [Score=89.0, Expect=3e-19]} {Dmel: FBgn0064123, stg1, stargazin-like protein, [Score=62.0, Expect=6e-10]} {Smed: dd_Smed_v6_20066_0_1, dd_Smed_v6_20066_0_1, [RH, Score=228, Expect=2e-68]} {RNA1310_39723} {RNA815_37605} |
41. | MligTC455_33854 | 41 | 0.85 | Mlig455_031601 | Neo: - Age: - Region-enriched R2: 5.730/0.00808 |
2.616 | 0.964 | - | - | 0.896 | 0.756 | - | Mlig455_031601 {REF} {Length: 1072} {RNA1310_42312} {RNA815_56269} | |
42. | MligTC455_02258 | 14 | 0.29 | Mlig455_004819, Mlig455_004888, Mlig455_004900 | Neo: - Age: - |
SLC9B2 | 2.598 | - | - | 1.000 | 0.792 | 0.806 | - | Mlig455_004819 {REF} {Length: 2596} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=54.1]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=125, Expect=5e-31]; ENSG00000164037, SLC9B1, solute carrier family 9 member B1, [Score=119, Expect=4e-29]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [Score=128, Expect=4e-32]; ENSMUSG00000037994, Slc9b2, solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2, [Score=128, Expect=3e-32]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [Score=115, Expect=1e-27]} {Celegans: WBGene00009618, F41E7.2, [Score=52.8, Expect=3e-07]} {Smed: dd_Smed_v6_7736_0_1, dd_Smed_v6_7736_0_1, [Score=126, Expect=1e-33]} {RNA1310_33802} Mlig455_004888 {REF} {Length: 2402} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=115.6]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=325, Expect=5e-102]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=326, Expect=6e-102]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [RH, Score=289, Expect=1e-86]} {Celegans: WBGene00009618, F41E7.2, [Score=138, Expect=3e-34]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=361, Expect=1e-116]} {RNA1310_33802} Mlig455_004900 {REF} {Length: 3013} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=115.6]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=325, Expect=6e-102]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=326, Expect=5e-102]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [RH, Score=289, Expect=2e-86]} {Celegans: WBGene00009618, F41E7.2, [Score=139, Expect=2e-34]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=361, Expect=2e-116]} {RNA1509_37253} {RNA1310_95649} {RNA815_29346.1} |
43. | MligTC455_18309 | 17 | 0.35 | Mlig455_056133 | Neo: - Age: - |
2.591 | 0.978 | - | 0.778 | - | 0.835 | - | Mlig455_056133 {REF} {Length: 1429} {RNA1310_65004} | |
44. | MligTC455_19041 | 54 | 1.12 | Mlig455_030662 | Neo: - Age: - Region-enriched R2: 9.337/0.00002 |
CAV1 | 2.569 | 0.952 | - | - | 0.861 | 0.756 | - | Mlig455_030662 {REF} {Length: 940} {Pfam: Caveolin [PF01146.19, score=117.8]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=98.2, Expect=1e-26]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=99.4, Expect=3e-27]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.9, Expect=6e-17]} {Smed: dd_Smed_v6_6535_0_1, dd_Smed_v6_6535_0_1, [RH, Score=133, Expect=6e-41]} {RNA1509_53325} {RNA1310_97043} {RNA815_32565} |
45. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
2.561 | 0.962 | - | - | 0.819 | 0.780 | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
46. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 2.56 | 0.968 | - | - | 0.876 | 0.716 | - | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
47. | MligTC455_28695 | 95 | 1.98 | Mlig455_033490 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.072/0.04773 |
PLCH2 | 2.54 | 0.964 | - | - | 0.725 | 0.851 | - | Mlig455_033490 {REF} {Length: 13918} {tRNA: Undet(NNN),pseudo, score=20.5} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=104.2]; RasGEF domain [PF00617.21, score=53.7]; Ras association (RalGDS/AF-6) domain [PF00788.25, score=44.8]; FERM central domain [PF00373.20, score=29.5]; C2 domain [PF00168.32, score=27.4]; Ankyrin repeat [PF00023.32, score=22.4]; Ankyrin repeats (3 copies) [PF12796.9, score=21.4]} {Human: ENSG00000276429, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]; ENSG00000149527, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]} {Mouse: ENSMUSG00000024998, Plce1, phospholipase C, epsilon 1, [RH, Score=281, Expect=4e-75]} {Dmel: FBgn0003416, sl, small wing, [Score=167, Expect=1e-40]} {Celegans: WBGene00004036, plc-1, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, [Score=248, Expect=3e-65]} {Smed: dd_Smed_v6_9716_1_1, dd_Smed_v6_9716_1_1, [RH, Score=739, Expect=0.0]} {RNA1509_26054} {RNA1310_1143.2, RNA1509_26054} {RNA1509_26054, RNA815_10233} |
48. | MligTC455_33495 | 28 | 0.58 | Mlig455_047292, Mlig455_047342, Mlig455_069323 | Neo: - Age: - |
LHFPL2 | 2.54 | 0.716 | - | 1.000 | - | 0.824 | - | Mlig455_047292 {REF} {Length: 1105} {RNA1310_118047} Mlig455_047342 {REF} {Length: 1735} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=104.8]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=30.7]} {Human: ENSG00000145685, LHFPL2, LHFPL tetraspan subfamily member 2, [Score=47.8, Expect=1e-05]} {Mouse: ENSMUSG00000045312, Lhfpl2, lipoma HMGIC fusion partner-like 2, [Score=47.0, Expect=1e-05]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [Score=175, Expect=1e-51]} {RNA1509_30020} {RNA1310_118047} {RNA815_5159.1} Mlig455_069323 {REF} {Length: 886} {RNA1310_118047} |
49. | MligTC455_44954 | 1303 | 27.14 | Mlig455_029595, Mlig455_070648 | Neo: Int S/G2/M Age: Down-Up-Up, logFC(26M/2M)=1.023 Region-specific R2: 8.846 Region-enriched R2: 10.764/0.00000 |
2.536 | 0.738 | - | 0.841 | 0.957 | - | - | Mlig455_029595 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871} {RNA1310_66833.2} {RNA815_41767} Mlig455_070648 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871, RNA1509_39484} {RNA1310_66833.2, RNA1509_20871, RNA1509_39484} {RNA1509_20871, RNA1509_39484, RNA815_41767} |
|
50. | MligTC455_46903 | 255 | 5.3 | Mlig455_040553 | Neo: - Age: - Region-enriched R2: 9.597/0.00026 |
2.522 | 0.809 | - | 0.991 | 0.722 | - | - | Mlig455_040553 {REF} {Length: 562} {RNA1509_45949} {RNA1310_70304, RNA1509_45949} {RNA1509_45949, RNA815_37653} | |
51. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
2.471 | 0.964 | - | 0.701 | 0.806 | - | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
52. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
2.462 | 0.972 | - | - | 0.719 | 0.771 | - | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
53. | MligTC455_15099 | 26 | 0.54 | Mlig455_057991, Mlig455_058185 | Neo: - Age: - Region-enriched R4: 8.074/0.00255 |
PCDH9 | 1.962 | 0.962 | - | 1.000 | - | - | - | Mlig455_057991 {REF} {Length: 5180} {Pfam: Cadherin domain [PF00028.19, score=245.9]; Cadherin-like [PF16184.7, score=32.1]; Cadherin-like [PF08266.14, score=31.0]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=277, Expect=2e-77]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=277, Expect=4e-77]} {Dmel: FBgn0001075, ft, fat, [Score=211, Expect=5e-55]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=171, Expect=7e-43]} {Smed: dd_Smed_v6_16566_0_2, dd_Smed_v6_16566_0_2, [Score=317, Expect=1e-92]} {RNA1509_38512} {RNA1310_81930} Mlig455_058185 {REF} {Length: 2168} {RNA1310_95463.1} |
54. | MligTC455_11776 | 33 | 0.68 | Mlig455_048959 | Neo: - Age: - |
GABBR2 | 1.957 | - | - | 1.000 | 0.957 | - | - | Mlig455_048959 {REF} {Length: 2499} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=162.7]; Receptor family ligand binding region [PF01094.30, score=94.2]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=277, Expect=2e-80]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=273, Expect=5e-79]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=252, Expect=4e-72]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=251, Expect=6e-72]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=134, Expect=4e-35]} {RNA1310_72017} {RNA815_50524} |
55. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 1.955 | - | - | 0.990 | 0.965 | - | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
56. | MligTC455_08590 | 6 | 0.12 | Mlig455_020569 | Neo: - Age: - |
PHOX2B | 1.954 | - | - | 1.000 | 0.954 | - | - | Mlig455_020569 {REF} {Length: 1405} {Pfam: Homeodomain [PF00046.31, score=79.7]} {Human: ENSG00000109132, PHOX2B, paired like homeobox 2B, [RH, Score=135, Expect=4e-36]; ENSG00000165462, PHOX2A, paired like homeobox 2A, [RH, Score=129, Expect=2e-34]} {Mouse: ENSMUSG00000012520, Phox2b, paired-like homeobox 2b, [RH, Score=135, Expect=3e-36]; ENSMUSG00000007946, Phox2a, paired-like homeobox 2a, [RH, Score=129, Expect=1e-34]} {Dmel: FBgn0025334, PHDP, Putative homeodomain protein, [RH, Score=119, Expect=3e-31]} {Celegans: WBGene00000440, ceh-17, C. Elegans Homeobox; CEH-17, [RH, Score=131, Expect=5e-36]} {Smed: dd_Smed_v6_29211_0_1, dd_Smed_v6_29211_0_1, [RH, Score=145, Expect=3e-40]} {RNA1310_111052} |
57. | MligTC455_08592 | 6 | 0.12 | Mlig455_044521 | Neo: - Age: - |
PHOX2B | 1.954 | - | - | 1.000 | 0.954 | - | - | Mlig455_044521 {REF} {Length: 1009} {Pfam: Homeodomain [PF00046.31, score=81.3]} {Human: ENSG00000109132, PHOX2B, paired like homeobox 2B, [RH, Score=131, Expect=4e-36]; ENSG00000165462, PHOX2A, paired like homeobox 2A, [RH, Score=130, Expect=7e-36]} {Mouse: ENSMUSG00000012520, Phox2b, paired-like homeobox 2b, [RH, Score=131, Expect=2e-36]; ENSMUSG00000007946, Phox2a, paired-like homeobox 2a, [RH, Score=130, Expect=3e-36]} {Dmel: FBgn0025334, PHDP, Putative homeodomain protein, [RH, Score=119, Expect=1e-32]} {Celegans: WBGene00000440, ceh-17, C. Elegans Homeobox; CEH-17, [Score=132, Expect=1e-37]} {Smed: dd_Smed_v6_29211_0_1, dd_Smed_v6_29211_0_1, [RH, Score=144, Expect=5e-41]} {RNA1310_111052} |
58. | MligTC455_15353 | 85 | 1.78 | Mlig455_015663, Mlig455_062473 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.265 Region-enriched R2: 9.386/0.02025 |
ARRB1 | 1.952 | - | - | 0.995 | 0.957 | - | - | Mlig455_015663 {REF} {Length: 1700} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=68.5]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=52.0]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=261, Expect=1e-83]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=260, Expect=5e-83]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=259, Expect=1e-82]; ENSMUSG00000060890, Arr3, arrestin 3, retinal, [Score=253, Expect=9e-81]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=252, Expect=6e-80]} {Dmel: FBgn0040206, krz, kurtz, [Score=256, Expect=3e-81]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=235, Expect=2e-73]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=321, Expect=4e-106]} {RNA1509_59210} {RNA1310_21679, RNA1509_59210} {RNA1509_59210, RNA815_10578.1} Mlig455_062473 {REF} {Length: 1703} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=71.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=57.4]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=268, Expect=5e-86]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=268, Expect=4e-86]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=265, Expect=5e-85]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=260, Expect=5e-83]} {Dmel: FBgn0040206, krz, kurtz, [Score=259, Expect=3e-82]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=239, Expect=8e-75]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=328, Expect=3e-109]} {RNA1509_59210} {RNA1310_21679} {RNA815_10578.1} |
59. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.945 | 0.945 | - | 1.000 | - | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
60. | MligTC455_56420 | 35 | 0.72 | Mlig455_064962 | Neo: - Age: - |
1.943 | - | - | 1.000 | - | 0.943 | - | Mlig455_064962 {REF} {Length: 368} {RNA1509_38728} {RNA1310_9789} {RNA815_21216} | |
61. | MligTC455_18505 | 15 | 0.31 | Mlig455_017536 | Neo: - Age: - |
1.942 | - | - | 1.000 | 0.942 | - | - | Mlig455_017536 {REF} {Length: 2174} {RNA1310_61282} {RNA815_41334} | |
62. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
1.935 | - | - | 0.969 | 0.966 | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
63. | MligTC455_12671 | 38 | 0.79 | Mlig455_038144, Mlig455_039808 | Neo: - Age: - |
1.933 | - | - | 0.950 | 0.983 | - | - | Mlig455_038144 {REF} {Length: 650} {RNA1310_68328} {RNA815_32749} Mlig455_039808 {REF} {Length: 815} {RNA1310_68328} {RNA815_32749} |
|
64. | MligTC455_33264 | 88 | 1.84 | Mlig455_055165 | Neo: - |
SLC17A8 | 1.933 | - | - | 0.983 | 0.950 | - | - | Mlig455_055165 {REF} {Length: 2530} {Pfam: Major Facilitator Superfamily [PF07690.18, score=65.4]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=129, Expect=5e-31]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=128, Expect=6e-31]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=124, Expect=1e-29]} {Mouse: ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=130, Expect=1e-31]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=130, Expect=2e-31]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=130, Expect=1e-31]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=112, Expect=6e-26]} {Celegans: WBGene00017681, slc-17.5, SLC (SoLute Carrier) homolog, [Score=66.6, Expect=2e-11]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=125, Expect=3e-30]} {RNA1509_54006} {RNA1310_10685, RNA1509_54006} {RNA1509_54006, RNA815_25744} |
65. | MligTC455_19487 | 14 | 0.28 | Mlig455_044811, Mlig455_055571 | Neo: - Age: - |
KCTD15 | 1.932 | 0.932 | - | 1.000 | - | - | - | Mlig455_044811 {REF} {Length: 1188} {Pfam: BTB/POZ domain [PF02214.24, score=67.6]} {Human: ENSG00000153885, KCTD15, potassium channel tetramerization domain containing 15, [RH, Score=253, Expect=3e-83]; ENSG00000134504, KCTD1, potassium channel tetramerization domain containing 1, [RH, Score=243, Expect=1e-73]} {Mouse: ENSMUSG00000030499, Kctd15, potassium channel tetramerisation domain containing 15, [RH, Score=254, Expect=6e-84]; ENSMUSG00000036225, Kctd1, potassium channel tetramerisation domain containing 1, [RH, Score=243, Expect=1e-73]} {Dmel: FBgn0034636, twz, tiwaz, [RH, Score=252, Expect=2e-82]} {Celegans: WBGene00016549, C40A11.6, [Score=57.4, Expect=1e-09]} {Smed: dd_Smed_v6_28887_0_1, dd_Smed_v6_28887_0_1, [RH, Score=184, Expect=3e-56]} {RNA1509_6075} {RNA1310_4175} {RNA815_1202.1} Mlig455_055571 {REF} {Length: 1181} {Pfam: BTB/POZ domain [PF02214.24, score=67.2]} {Human: ENSG00000153885, KCTD15, potassium channel tetramerization domain containing 15, [RH, Score=253, Expect=3e-83]; ENSG00000134504, KCTD1, potassium channel tetramerization domain containing 1, [RH, Score=243, Expect=2e-73]} {Mouse: ENSMUSG00000030499, Kctd15, potassium channel tetramerisation domain containing 15, [RH, Score=254, Expect=6e-84]; ENSMUSG00000036225, Kctd1, potassium channel tetramerisation domain containing 1, [RH, Score=243, Expect=1e-73]} {Dmel: FBgn0034636, twz, tiwaz, [RH, Score=250, Expect=1e-81]} {Celegans: WBGene00016549, C40A11.6, [Score=57.4, Expect=1e-09]} {Smed: dd_Smed_v6_28887_0_1, dd_Smed_v6_28887_0_1, [RH, Score=185, Expect=9e-57]} {RNA1509_6075} {RNA1310_4175} {RNA815_1202.1} |
66. | MligTC455_46712 | 29 | 0.6 | Mlig455_034008 | Neo: - Age: - |
1.931 | 0.933 | - | 0.998 | - | - | - | Mlig455_034008 {REF} {Length: 413} {RNA1509_3272} {RNA1310_44997} {RNA815_30824} | |
67. | MligTC455_10216 | 85 | 1.77 | Mlig455_028808 | Neo: - Age: - |
1.93 | 0.938 | - | 0.992 | - | - | - | Mlig455_028808 {REF} {Length: 1548} {RNA1509_32459} {RNA1310_2760.1} {RNA815_33964} | |
68. | MligTC455_17871 | 73 | 1.51 | Mlig455_059152, Mlig455_059165, Mlig455_065536 | Neo: - Age: - |
1.924 | 0.933 | - | 0.991 | - | - | - | Mlig455_059152 {REF} {Length: 321} {NoTransDecoderORF} Mlig455_059165 {REF} {Length: 3349} {Pfam: PIF1-like helicase [PF05970.16, score=103.7]; Helitron helicase-like domain at N-terminus [PF14214.8, score=34.7]} {Celegans: WBGene00018020, F33H12.6, [Score=246, Expect=7e-67]} {Smed: dd_Smed_v6_22430_0_5, dd_Smed_v6_22430_0_5, [Score=47.0, Expect=6e-07]} {RNA1310_3236.1} {RNA815_8758} Mlig455_065536 {REF} {Length: 321} {NoTransDecoderORF} |
|
69. | MligTC455_12113 | 72 | 1.5 | Mlig455_001687, Mlig455_071131 | Neo: - Age: - |
1.923 | 0.932 | - | 0.991 | - | - | - | Mlig455_001687 {REF} {Length: 809} {RNA1310_67367} {RNA815_37220} Mlig455_071131 {REF} {Length: 452} {RNA1509_45496} {RNA1310_67367} {RNA815_37220} |
|
70. | MligTC455_40334 | 37 | 0.77 | Mlig455_060664 | Neo: - Age: - |
1.921 | - | - | 0.980 | 0.941 | - | - | Mlig455_060664 {REF} {Length: 529} {RNA1509_15938} {RNA1310_60401} {RNA815_36308} | |
71. | MligTC455_12607 | 22 | 0.46 | Mlig455_022861 | Neo: - Age: - |
1.92 | - | - | 1.000 | 0.920 | - | - | Mlig455_022861 {REF} {Length: 614} {TRANSSPLICED} {RNA1310_92283} | |
72. | MligTC455_21033 | 1129 | 23.52 | Mlig455_010672 | Neo: - Age: logFC(26M/2M)=0.356 Region-specific R2: 3.326 Region-enriched R2: 2.739/0.00000 Regeneration-downregulated R2: -1.967 Regeneration-depleted R2: -1.967 |
1.919 | 0.951 | - | - | 0.968 | - | - | Mlig455_010672 {REF} {Length: 829} {RNA1509_30331, RNA1509_45731} {RNA1310_60944, RNA1509_30331, RNA1509_45731} {RNA1509_30331, RNA1509_45731, RNA815_27381.1} | |
73. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 1.919 | 0.967 | - | - | 0.952 | - | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
74. | MligTC455_34525 | 52 | 1.08 | Mlig455_021566 | Neo: - Age: Down-Up-Down |
GNAI1 | 1.917 | 0.946 | - | - | 0.971 | - | - | Mlig455_021566 {REF} {Length: 3532} {Pfam: G-protein alpha subunit [PF00503.22, score=404.9]; ADP-ribosylation factor family [PF00025.23, score=56.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=20.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.4]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=486, Expect=2e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=481, Expect=3e-169]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=474, Expect=1e-166]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=486, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=475, Expect=5e-167]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=474, Expect=1e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=468, Expect=2e-164]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=446, Expect=5e-156]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=598, Expect=0.0]} {RNA1509_45426} {RNA1310_26920, RNA1509_45426} {RNA1509_45426, RNA815_11718} |
75. | MligTC455_34232 | 35 | 0.73 | Mlig455_051899 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.310 Region-enriched R3: 6.749/0.02565 |
ACR | 1.916 | - | - | 0.984 | 0.932 | - | - | Mlig455_051899 {REF} {Length: 1242} {Pfam: Trypsin [PF00089.28, score=169.8]} {Human: ENSG00000100312, ACR, acrosin, [Score=154, Expect=5e-43]; ENSG00000283539, ACR, acrosin, [Score=154, Expect=5e-43]; ENSG00000198670, LPA, lipoprotein(a), [Score=152, Expect=3e-40]; ENSG00000122194, PLG, plasminogen, [Score=152, Expect=1e-40]; ENSG00000178297, TMPRSS9, transmembrane serine protease 9, [Score=148, Expect=5e-39]; ENSG00000103355, PRSS33, serine protease 33, [Score=148, Expect=5e-42]} {Mouse: ENSMUSG00000059481, Plg, plasminogen, [Score=150, Expect=5e-40]; ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=148, Expect=2e-39]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=144, Expect=6e-38]} {Dmel: FBgn0036287, CG10663, [Score=129, Expect=8e-33]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=122, Expect=2e-32]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [Score=172, Expect=4e-51]} {RNA1509_37786} {RNA1310_26421} {RNA815_13601} |
76. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
1.915 | 0.933 | - | - | 0.982 | - | - | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
77. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
1.914 | 0.971 | - | - | 0.943 | - | - | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
78. | MligTC455_17286 | 18 | 0.37 | Mlig455_062850, Mlig455_062932 | Neo: - Age: - |
NPFFR2, QRFPR | 1.911 | - | - | 0.957 | 0.954 | - | - | Mlig455_062850 {REF} {Length: 2774} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=136.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=17.9]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=132, Expect=1e-33]; ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=130, Expect=4e-33]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=137, Expect=9e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=138, Expect=9e-36]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205} Mlig455_062932 {REF} {Length: 1463} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=135.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=19.2]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=129, Expect=7e-33]; ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=128, Expect=2e-32]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=138, Expect=8e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=136, Expect=4e-35]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205} |
79. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
1.907 | 0.931 | - | - | 0.976 | - | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
80. | MligTC455_10299 | 72 | 1.51 | Mlig455_023028, Mlig455_023125, Mlig455_023183 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.617 Region-enriched R2: 4.572/0.04281 |
ANGPTL1 | 1.906 | 0.974 | - | - | 0.932 | - | - | Mlig455_023028 {REF} {Length: 2538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=8e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=112, Expect=1e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=114, Expect=2e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=112, Expect=9e-28]} {Dmel: FBgn0050280, CG30280, [Score=103, Expect=9e-26]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.8, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023125 {REF} {Length: 2398} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.5]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=1e-25]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=7e-26]} {Dmel: FBgn0050280, CG30280, [Score=92.8, Expect=6e-22]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=51.2, Expect=3e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023183 {REF} {Length: 2190} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=2e-28]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=110, Expect=9e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=113, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=110, Expect=6e-27]} {Dmel: FBgn0003326, sca, scabrous, [Score=104, Expect=8e-25]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.4, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} |
81. | MligTC455_35895 | 102 | 2.12 | Mlig455_063971 | Neo: - Age: - |
RYK | 1.906 | 0.955 | - | - | - | 0.951 | - | Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921} |
82. | MligTC455_41195 | 25 | 0.53 | Mlig455_017236 | Neo: - Age: - |
1.905 | - | - | 0.984 | 0.921 | - | - | Mlig455_017236 {REF} {Length: 591} {NoTransDecoderORF} {RNA1310_58555} {RNA815_29982} | |
83. | MligTC455_44327 | 94 | 1.95 | Mlig455_026126 | Neo: - Age: Down-Down-Down Region-enriched R5: 3.905/0.02515 |
1.905 | - | - | 0.989 | 0.916 | - | - | Mlig455_026126 {REF} {Length: 572} {RNA1509_32102} {RNA1310_60068} {RNA815_37486} | |
84. | MligTC455_25921 | 329 | 6.86 | Mlig455_006703 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-2.996 Region-enriched R2: 6.614/0.00492 |
1.905 | 0.943 | - | - | 0.962 | - | - | Mlig455_006703 {REF} {Length: 664} {RNA1509_22927} {RNA1310_80445} {RNA815_41771.1} | |
85. | MligTC455_24407 | 222 | 4.63 | Mlig455_044026 | Neo: - Age: Down-Up-Up Region-specific R2: 3.725 Region-enriched R2: 3.414/0.00001 |
1.902 | 0.947 | - | - | 0.955 | - | - | Mlig455_044026 {REF} {Length: 503} {RNA1509_54091} {RNA1310_68348.1} {RNA815_33570.1} | |
86. | MligTC455_16974 | 15 | 0.32 | Mlig455_052824 | Neo: - Age: - |
1.901 | 0.931 | - | - | 0.970 | - | - | Mlig455_052824 {REF} {Length: 306} {NoTransDecoderORF} {RNA1310_65069} {RNA815_35708.2} | |
87. | MligTC455_42484 | 246 | 5.12 | Mlig455_046416 | Neo: - Age: Down-Up-Down Region-specific R2: 4.313 Region-enriched R2: 2.983/0.00930 |
1.901 | 0.949 | - | - | 0.952 | - | - | Mlig455_046416 {REF} {Length: 1006} {RNA1310_40237.1} {RNA815_18246} | |
88. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
1.899 | 0.941 | - | - | 0.958 | - | - | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
89. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
1.896 | 0.933 | - | - | 0.963 | - | - | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
90. | MligTC455_17051 | 22 | 0.46 | Mlig455_042552 | Neo: - Age: - |
GRIA4 | 1.896 | 0.955 | - | - | 0.941 | - | - | Mlig455_042552 {REF} {Length: 3307} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=45.2]; Receptor family ligand binding region [PF01094.30, score=25.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.8]} {Human: ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=139, Expect=3e-33]} {Dmel: FBgn0038837, CG3822, [Score=142, Expect=2e-34]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=109, Expect=2e-24]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=246, Expect=7e-74]} {RNA1310_33224} {RNA815_17044} |
91. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
1.895 | 0.966 | - | 0.929 | - | - | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
92. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 1.892 | 0.970 | - | - | 0.922 | - | - | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
93. | MligTC455_37395 | 18 | 0.38 | Mlig455_071006 | Neo: - Age: - |
1.892 | - | - | 0.939 | - | 0.953 | - | Mlig455_071006 {REF} {Length: 898} {Pfam: Transcriptional Coactivator p15 (PC4) [PF02229.18, score=31.2]} {RNA1310_17986} {RNA815_61383} | |
94. | MligTC455_38774 | 13 | 0.28 | Mlig455_056173, Mlig455_058730 | Neo: - Age: - |
GALR2 | 1.892 | 0.892 | - | 1.000 | - | - | - | Mlig455_056173 {REF} {Length: 2381} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=152.4]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=35.1]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=20.1]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=50.4, Expect=4e-06]; ENSG00000180269, GPR139, G protein-coupled receptor 139, [Score=48.1, Expect=1e-05]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=53.5, Expect=2e-07]} {Dmel: FBgn0033579, CG13229, [Score=179, Expect=1e-51]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=218, Expect=1e-66]} {Smed: dd_Smed_v6_15468_0_1, dd_Smed_v6_15468_0_1, [Score=248, Expect=2e-78]} {RNA1310_25407.1} {RNA815_38269} Mlig455_058730 {REF} {Length: 2507} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=123.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=31.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Dmel: FBgn0033579, CG13229, [Score=139, Expect=6e-37]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=175, Expect=5e-50]} {Smed: dd_Smed_v6_15468_0_2, dd_Smed_v6_15468_0_2, [Score=209, Expect=2e-63]} {RNA1310_25407.1} {RNA815_42074} |
95. | MligTC455_42314 | 406 | 8.46 | Mlig455_052727 | Neo: - Age: - Region-enriched R2: 4.230/0.00183 |
1.892 | 0.942 | - | - | 0.950 | - | - | Mlig455_052727 {REF} {Length: 1339} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=19.1]} {RNA1509_51722} {RNA1310_50605} {RNA815_15783.1} | |
96. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
1.89 | 0.933 | - | - | 0.957 | - | - | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
97. | MligTC455_13866 | 60 | 1.26 | Mlig455_059198 | Neo: - Age: - |
1.888 | - | - | 0.957 | 0.931 | - | - | Mlig455_059198 {REF} {Length: 561} {NoTransDecoderORF} {RNA1310_89423} {RNA815_50610} | |
98. | MligTC455_16606 | 108 | 2.26 | Mlig455_034973, Mlig455_053711, Mlig455_060000 | Neo: - Age: - Region-enriched R2: 5.697/0.00617 |
GLRA2 | 1.887 | - | - | 0.935 | 0.952 | - | - | Mlig455_034973 {REF} {Length: 1000} {RNA1310_100434} Mlig455_053711 {REF} {Length: 2327} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=60.8, Expect=3e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=61.6, Expect=1e-09]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1310_56609} {RNA815_37711} Mlig455_060000 {REF} {Length: 2781} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=62.0, Expect=1e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=62.0, Expect=7e-10]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=62.0, Expect=7e-10]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=5e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1509_50322} {RNA1310_56609} {RNA815_37711} |
99. | MligTC455_39544 | 611 | 12.73 | Mlig455_001809, Mlig455_001836, Mlig455_062227, Mlig455_062236 | Neo: - Age: - Region-specific R2: 8.576 Region-enriched R2: 8.112/0.00016 |
1.887 | 0.932 | - | - | 0.955 | - | - | Mlig455_001809 {REF} {Length: 1067} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} Mlig455_001836 {REF} {Length: 1065} {RNA1509_52939} {RNA1310_72581, RNA1509_52939} {RNA1509_52939, RNA815_24546} Mlig455_062227 {REF} {Length: 3520} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} Mlig455_062236 {REF} {Length: 620} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} |
|
100. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
1.886 | 0.934 | - | - | 0.952 | - | - | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} |